Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6833
Gene Symbol: ABCC8
ABCC8
0.110 Biomarker disease HPO
Entrez Id: 6833
Gene Symbol: ABCC8
ABCC8
0.110 GeneticVariation disease BEFREE We studied a male infant with compound heterozygous ABCC8 mutations (p.Arg826Trp/p.Ile93Thr) causing neonatal diabetes mellitus.He died of ketoacidosis. 24941889 2014
Entrez Id: 30
Gene Symbol: ACAA1
ACAA1
0.010 Biomarker disease BEFREE Deficiency of beta-ketothiolase (beta-KT, also known as T2, mitochondrial acetoacetyl-CoA thiolase and acetyl-CoA acetyltransferase 1) is a well-described disorder which presents with acute episodic ketoacidosis. 16950638 2006
Entrez Id: 10449
Gene Symbol: ACAA2
ACAA2
0.010 Biomarker disease BEFREE Deficiency of beta-ketothiolase (beta-KT, also known as T2, mitochondrial acetoacetyl-CoA thiolase and acetyl-CoA acetyltransferase 1) is a well-described disorder which presents with acute episodic ketoacidosis. 16950638 2006
Entrez Id: 34
Gene Symbol: ACADM
ACADM
0.100 Biomarker disease HPO
Entrez Id: 38
Gene Symbol: ACAT1
ACAT1
0.130 AlteredExpression disease BEFREE Deficiency of ACAT1 is an inherited metabolic disorder, which results from a defect in mitochondrial acetoacetyl-CoA thiolase activity and is clinically characterized with patients presenting ketoacidosis. 31228515 2019
Entrez Id: 38
Gene Symbol: ACAT1
ACAT1
0.130 GeneticVariation disease BEFREE It is caused by mutations in the ACAT1 gene and may present with metabolic ketoacidosis. 28689740 2017
Entrez Id: 38
Gene Symbol: ACAT1
ACAT1
0.130 Biomarker disease BEFREE If beta-KT deficiency is diagnosed early and treated by fasting avoidance and modest protein restriction, ketoacidosis episodes can be prevented and the prognosis is excellent. 16950638 2006
Entrez Id: 38
Gene Symbol: ACAT1
ACAT1
0.130 Biomarker disease HPO
Entrez Id: 52
Gene Symbol: ACP1
ACP1
0.010 Biomarker disease BEFREE Ketoacidosis and HbA1C show a similar pattern of relationship with ACP1. 12640337 2003
Entrez Id: 197322
Gene Symbol: ACSF3
ACSF3
0.100 Biomarker disease HPO
Entrez Id: 125
Gene Symbol: ADH1B
ADH1B
0.010 GeneticVariation disease BEFREE The faster metabolism of ethanol and acetaldehyde by the ADH1B*2 allele and ALDH2*1/*1 genotype and higher ketosis levels were associated with higher UA levels in alcoholics, while diabetes and the consumption of sake were negative determinants. 26542604 2016
Entrez Id: 197
Gene Symbol: AHSG
AHSG
0.010 Biomarker disease BEFREE ITIH4 and CD46 increased, and AHSG and ORM1 decreased before the onset of ketosis. 29154737 2017
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.010 AlteredExpression disease BEFREE The correlation between levels of ketosis and hypoxic inducible factor-1alpha (HIF-1α), AKT (also known as protein kinase B or PKB) and 5' AMP-activated protein kinase (AMPK) were determined. 28685447 2017
Entrez Id: 208
Gene Symbol: AKT2
AKT2
0.010 AlteredExpression disease BEFREE The correlation between levels of ketosis and hypoxic inducible factor-1alpha (HIF-1α), AKT (also known as protein kinase B or PKB) and 5' AMP-activated protein kinase (AMPK) were determined. 28685447 2017
Entrez Id: 217
Gene Symbol: ALDH2
ALDH2
0.010 GeneticVariation disease BEFREE The faster metabolism of ethanol and acetaldehyde by the ADH1B*2 allele and ALDH2*1/*1 genotype and higher ketosis levels were associated with higher UA levels in alcoholics, while diabetes and the consumption of sake were negative determinants. 26542604 2016
Entrez Id: 55911
Gene Symbol: APOBR
APOBR
0.010 Biomarker disease BEFREE Most interestingly, several candidate genes, including previously reported genes (BMP4, HNF4A and APOBR) and newly identified genes (SOCS4, GCH1, ATG14, RGS6, CYP7A1 and MAPK3), are involved in insulin metabolism or lipid metabolism, implicating the contribution of energy-metabolism-associated genes to the genetic basis of KET. 31179571 2019
Entrez Id: 348
Gene Symbol: APOE
APOE
0.010 GeneticVariation disease BEFREE Variants in APOE, IL1B and IDE may influence the cognitive response to induced ketosis in patients with mild to moderate AD. 21992747 2011
Entrez Id: 22863
Gene Symbol: ATG14
ATG14
0.010 Biomarker disease BEFREE Most interestingly, several candidate genes, including previously reported genes (BMP4, HNF4A and APOBR) and newly identified genes (SOCS4, GCH1, ATG14, RGS6, CYP7A1 and MAPK3), are involved in insulin metabolism or lipid metabolism, implicating the contribution of energy-metabolism-associated genes to the genetic basis of KET. 31179571 2019
Entrez Id: 513
Gene Symbol: ATP5F1D
ATP5F1D
0.100 Biomarker disease HPO
Entrez Id: 593
Gene Symbol: BCKDHA
BCKDHA
0.100 Biomarker disease HPO
Entrez Id: 594
Gene Symbol: BCKDHB
BCKDHB
0.100 Biomarker disease HPO
Entrez Id: 632
Gene Symbol: BGLAP
BGLAP
0.010 GeneticVariation disease BEFREE The inverse dose-dependent relationship of osteocalcin and risk of ketosis was present across osteocalcin level quintiles (top quintile as the reference, adjusted odds ratio (95%CI) = 2.56 (0.80-8.17), 3.71 (0.90-15.29), 10.77 (2.63-44.15), 23.81 (4.32-131.17) per osteocalcin quintile respectively). 31850672 2019
Entrez Id: 652
Gene Symbol: BMP4
BMP4
0.010 GeneticVariation disease BEFREE Most interestingly, several candidate genes, including previously reported genes (BMP4, HNF4A and APOBR) and newly identified genes (SOCS4, GCH1, ATG14, RGS6, CYP7A1 and MAPK3), are involved in insulin metabolism or lipid metabolism, implicating the contribution of energy-metabolism-associated genes to the genetic basis of KET. 31179571 2019
Entrez Id: 763
Gene Symbol: CA5A
CA5A
0.100 Biomarker disease HPO